Eugene Moylan

714 total citations
33 papers, 552 citations indexed

About

Eugene Moylan is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Eugene Moylan has authored 33 papers receiving a total of 552 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 6 papers in Cancer Research. Recurrent topics in Eugene Moylan's work include Cancer Treatment and Pharmacology (7 papers), Breast Cancer Treatment Studies (6 papers) and Advanced Breast Cancer Therapies (4 papers). Eugene Moylan is often cited by papers focused on Cancer Treatment and Pharmacology (7 papers), Breast Cancer Treatment Studies (6 papers) and Advanced Breast Cancer Therapies (4 papers). Eugene Moylan collaborates with scholars based in Australia, Ireland and United States. Eugene Moylan's co-authors include Séamus O’Reilly, Min Yuen Teo, Niamh Bermingham, Catherine Drake, Stuart A. Grossman, Catherine Keohane, Susan Murray, Richard Bambury, Arié Figer and Hanno Riess and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Eugene Moylan

30 papers receiving 540 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eugene Moylan Australia 11 340 127 111 110 91 33 552
Catharina Bartmann Germany 11 137 0.4× 78 0.6× 48 0.4× 112 1.0× 104 1.1× 29 476
Tomoko Tamaki Japan 9 123 0.4× 65 0.5× 124 1.1× 97 0.9× 129 1.4× 26 566
Wojciech Rogowski Poland 12 286 0.8× 40 0.3× 180 1.6× 80 0.7× 204 2.2× 40 650
Émmanuelle Vigarios France 12 402 1.2× 82 0.6× 96 0.9× 97 0.9× 119 1.3× 39 729
Kirsten Herbert Australia 14 210 0.6× 154 1.2× 46 0.4× 128 1.2× 82 0.9× 26 684
Niloufer Khan United States 8 504 1.5× 34 0.3× 139 1.3× 152 1.4× 109 1.2× 26 724
Paola De Lorenzo Italy 20 241 0.7× 119 0.9× 68 0.6× 87 0.8× 378 4.2× 50 1.5k
Justyna Kanold France 15 109 0.3× 62 0.5× 63 0.6× 108 1.0× 72 0.8× 50 638
Abraham Klepfish Israel 12 151 0.4× 158 1.2× 41 0.4× 139 1.3× 63 0.7× 21 486
T.B. Johannesen Norway 11 142 0.4× 71 0.6× 111 1.0× 32 0.3× 91 1.0× 17 472

Countries citing papers authored by Eugene Moylan

Since Specialization
Citations

This map shows the geographic impact of Eugene Moylan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugene Moylan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugene Moylan more than expected).

Fields of papers citing papers by Eugene Moylan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eugene Moylan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugene Moylan. The network helps show where Eugene Moylan may publish in the future.

Co-authorship network of co-authors of Eugene Moylan

This figure shows the co-authorship network connecting the top 25 collaborators of Eugene Moylan. A scholar is included among the top collaborators of Eugene Moylan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugene Moylan. Eugene Moylan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Prasanna, Thiru, Laeeq Malik, Robert McCuaig, et al.. (2022). A Phase 1 Proof of Concept Study Evaluating the Addition of an LSD1 Inhibitor to Nab-Paclitaxel in Advanced or Metastatic Breast Cancer (EPI-PRIMED). Frontiers in Oncology. 12. 862427–862427. 14 indexed citations
2.
3.
Zhao, Qi, Geoff P. Delaney, Eugene Moylan, et al.. (2020). Acupuncture for Cancer Related Pain: Protocol for a Pragmatic Randomised Wait-List Controlled Trial. Integrative Cancer Therapies. 19. 1872195011–1872195011. 2 indexed citations
4.
Wilson, Brooke E., et al.. (2019). Association between ribociclib and changes in creatinine in patients with hormone receptor positive metastatic breast cancer. Internal Medicine Journal. 49(11). 1438–1442. 11 indexed citations
5.
Moylan, Eugene, et al.. (2019). Survival and cardiac toxicity in patients with HER2‐positive, metastatic breast cancer treated with trastuzumab in routine clinical practice. Asia-Pacific Journal of Clinical Oncology. 16(1). 34–38. 2 indexed citations
6.
Tervonen, Hanna, Enmoore Lin, Frances Boyle, et al.. (2019). Risk of emergency hospitalisation and survival outcomes following adjuvant chemotherapy for early breast cancer in New South Wales, Australia. European Journal of Cancer Care. 28(5). e13125–e13125. 2 indexed citations
7.
Zhu, Xiaoshu, et al.. (2016). Herbal Medicine for Hot Flushes Induced by Endocrine Therapy in Women with Breast Cancer: A Systematic Review and Meta‐Analysis. Evidence-based Complementary and Alternative Medicine. 2016(1). 1327251–1327251. 12 indexed citations
8.
Schofield, Penelope, Martin R. Stockler, Diana Zannino, et al.. (2015). Hope, optimism and survival in a randomised trial of chemotherapy for metastatic colorectal cancer. Supportive Care in Cancer. 24(1). 401–408. 32 indexed citations
9.
Bambury, Richard, Min Yuen Teo, Susan Murray, et al.. (2013). The association of pre-treatment neutrophil to lymphocyte ratio with overall survival in patients with glioblastoma multiforme. Journal of Neuro-Oncology. 114(1). 149–154. 184 indexed citations
10.
Graham, Donna M., et al.. (2013). Oral anticancer medication: Does the patient understand?. Journal of Clinical Oncology. 31(31_suppl). 219–219.
11.
MacEneaney, Peter, et al.. (2011). Reversible posterior leukoencephalopathy induced by carboplatin and etoposide. Medical Oncology. 29(2). 1287–1291. 10 indexed citations
12.
Forde, Patrick M., et al.. (2011). A 27-year-old man with diplopia, fatiguable ptosis and rash: a rare presentation of angiocentric T cell lymphoma with lymphomatoid vasculitis. BMJ Case Reports. 2011. bcr0620103118–bcr0620103118. 2 indexed citations
13.
Schofield, Philip, Martin R. Stockler, Diana Zannino, et al.. (2010). Hope, optimism, and survival in a randomized trial of first-line chemotherapy for patients with metastatic colorectal cancer.. Journal of Clinical Oncology. 28(15_suppl). 9039–9039. 1 indexed citations
14.
O’Reilly, Séamus, et al.. (2009). Safety of trastuzumab (Herceptin®) during pregnancy: two case reports. Cases Journal. 2(1). 9329–9329. 19 indexed citations
15.
Ellis, Peter, Geoff P. Delaney, Stephen Della‐Fiorentina, & Eugene Moylan. (2004). Assessing outcomes of cancer care: Lessons to be learned from a retrospective review of the management of small cell lung cancer at the Cancer Therapy Centre, Liverpool Hospital, January 1996−July 2000. Australasian Radiology. 48(3). 364–370. 4 indexed citations
16.
Delaney, Geoff P., et al.. (2002). The Development of a Model of Outpatient Chemotherapy Delivery – Chemotherapy Basic Treatment Equivalent (CBTE). Clinical Oncology. 14(5). 406–412. 10 indexed citations
17.
Punt, Cornelis J.A., Attila Nagy, Jean-Yves Douillard, et al.. (2002). Edrecolomab alone or in combination with fluorouracil and folinic acid in the adjuvant treatment of stage III colon cancer: a randomised study. The Lancet. 360(9334). 671–677. 159 indexed citations
18.
Bahrani, Bassim Al, David J. Thomas, & Eugene Moylan. (2001). What's causing that gas?. The Medical Journal of Australia. 174(12). 652–652. 10 indexed citations
19.
Patterson, Patricia, et al.. (2000). Needs Analysis of a Cancer Education Program in South Western Sydney. Cancer Nursing. 23(3). 186–192. 14 indexed citations
20.
Macleod, Colin, Eugene Moylan, & Gregory L. Falk. (1997). Carcinoma of the esophagus treated with radical chemoradiation 19 years after irradiation for recurrent breast cancer. Diseases of the Esophagus. 10(2). 145–148. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Catharina Bartmann Breakdown of academic impact, for papers by Tomoko Tamaki Breakdown of academic impact, for papers by Wojciech Rogowski Breakdown of academic impact, for papers by Émmanuelle Vigarios Breakdown of academic impact, for papers by Kirsten Herbert Breakdown of academic impact, for papers by Niloufer Khan Breakdown of academic impact, for papers by Paola De Lorenzo Breakdown of academic impact, for papers by Justyna Kanold Breakdown of academic impact, for papers by Abraham Klepfish Breakdown of academic impact, for papers by T.B. Johannesen
Rankless by CCL
2026